NFE2L2 and cancer: Thus, activating NRF2/KEAP1 signaling to protect cells from ROS has been widely acknowledged as a promising therapeutic strategy to alter redox equilibration of ROS-related chronic diseases, including cancer (Jeong et al., 2006).